Literature DB >> 21786003

[Livedoid vasculopathy. Pathogenesis, diagnosis and treatment of cutaneous infarction].

T Goerge1.   

Abstract

Livedo vasculopathy is a chronic recurrent disease of the cutaneous circulation and is characterized by episodic occurrence of painful ulcerations of the lower leg. These heal slowly leaving small porcelain-white scars called atrophie blanche. Recent research has shown that livedoid vasculopathy is a coagulation disorder classified as a vasculopathy different from inflammatory vasculitis. Distinguishing between the disorders enhances the pathophysiologic understanding and supports the therapeutic rationale. The prevention of irreversible residual scarring is the main goal in treating cutaneous infarction; prompt treatment is required.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21786003     DOI： 10.1007/s00105-011-2172-3

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


  20 in total

1.  Treatment of livedoid vasculopathy with low-molecular-weight heparin: report of 2 cases.

Authors:  Bethany R Hairston; Mark D P Davis; Lawrence E Gibson; Lisa A Drage
Journal:  Arch Dermatol       Date:  2003-08

2.  Livedo reticularis with summer ulcerations.

Authors:  M FELDAKER; E A HINES; R R KIERLAND
Journal:  AMA Arch Derm       Date:  1955-07

3.  Livedoid vasculopathy in a pediatric patient with elevated lipoprotein(a) levels: prompt response to continuous low-molecular-weight heparin.

Authors:  Tobias Goerge; Carsten Weishaupt; Dieter Metze; Ulrike Nowak-Göttl; Cord Sunderkötter; Martin Steinhoff; Stefan W Schneider
Journal:  Arch Dermatol       Date:  2010-08

4.  Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia.

Authors:  Catherine E Browning; Jeffrey P Callen
Journal:  Arch Dermatol       Date:  2006-01

5.  Livedo vasculopathy vs small vessel cutaneous vasculitis: cytokine and platelet P-selectin studies.

Authors:  M Papi; B Didona; O De Pità; A Frezzolini; S Di Giulio; W De Matteis; D Del Principe; R Cavalieri
Journal:  Arch Dermatol       Date:  1998-04

Review 6.  [Atrophie blanche (so-called capillaritis alba)].

Authors:  J Metz; G Sturm
Journal:  Hautarzt       Date:  1974-03       Impact factor: 0.751

7.  Atrophie blanche: periodic painful ulcers of lower extremities. A clinical and histopathological entity.

Authors:  H R Gray; J H Graham; W Johnson; C F Burgoon
Journal:  Arch Dermatol       Date:  1966-02

8.  Livedo vasculitis. Segmental hyalinizing vasculitis of the dermis.

Authors:  J W Bard; R K Winkelmann
Journal:  Arch Dermatol       Date:  1967-11

9.  Use of intravenous immunoglobulin in livedo vasculitis.

Authors:  H Amital; Y Levy; Y Shoenfeld
Journal:  Clin Exp Rheumatol       Date:  2000 May-Jun       Impact factor: 4.473

10.  Pulsed intravenous immunoglobulin therapy in livedoid vasculitis: an open trial evaluating 9 consecutive patients.

Authors:  Alexander Kreuter; Thilo Gambichler; Frank Breuckmann; Falk G Bechara; Sebastian Rotterdam; Markus Stücker; Peter Altmeyer
Journal:  J Am Acad Dermatol       Date:  2004-10       Impact factor: 11.527
View more
  3 in total

Review 1.  [Leg discoloration].

Authors:  L Unger; U Wollina; J Machetanz; C Stelzner; S Schellong
Journal:  Internist (Berl)       Date:  2013-11       Impact factor: 0.743

2.  A Phase II Multicenter Trial With Rivaroxaban in the Treatment of Livedoid Vasculopathy Assessing Pain on a Visual Analog Scale.

Authors:  Attyla Drabik; Carina Hillgruber; Tobias Goerge
Journal:  JMIR Res Protoc       Date:  2014-12-10

3.  Livedoid vasculopathy - A diagnostic and therapeutic challenge.

Authors:  Maria Rosa Burg; Carolin Mitschang; Tobias Goerge; Stefan Werner Schneider
Journal:  Front Med (Lausanne)       Date:  2022-10-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.